Orion Oyj
OMXH:ORNBV
Orion Oyj?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
32.27
57.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Orion Oyj hold over its rivals?
What risks and challenges
does Orion Oyj face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Orion Oyj.
Provide an overview of the primary business activities
of Orion Oyj.
What unique competitive advantages
does Orion Oyj hold over its rivals?
What risks and challenges
does Orion Oyj face in the near future?
Summarize the latest earnings call
of Orion Oyj.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Orion Oyj.
Provide P/S
for Orion Oyj.
Provide P/E
for Orion Oyj.
Provide P/OCF
for Orion Oyj.
Provide P/FCFE
for Orion Oyj.
Provide P/B
for Orion Oyj.
Provide EV/S
for Orion Oyj.
Provide EV/GP
for Orion Oyj.
Provide EV/EBITDA
for Orion Oyj.
Provide EV/EBIT
for Orion Oyj.
Provide EV/OCF
for Orion Oyj.
Provide EV/FCFF
for Orion Oyj.
Provide EV/IC
for Orion Oyj.
Show me price targets
for Orion Oyj made by professional analysts.
What are the Revenue projections
for Orion Oyj?
How accurate were the past Revenue estimates
for Orion Oyj?
What are the Net Income projections
for Orion Oyj?
How accurate were the past Net Income estimates
for Orion Oyj?
What are the EPS projections
for Orion Oyj?
How accurate were the past EPS estimates
for Orion Oyj?
What are the EBIT projections
for Orion Oyj?
How accurate were the past EBIT estimates
for Orion Oyj?
Compare the revenue forecasts
for Orion Oyj with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Orion Oyj and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Orion Oyj against its competitors.
Analyze the profit margins
(gross, operating, and net) of Orion Oyj compared to its peers.
Compare the P/E ratios
of Orion Oyj against its peers.
Discuss the investment returns and shareholder value creation
comparing Orion Oyj with its peers.
Analyze the financial leverage
of Orion Oyj compared to its main competitors.
Show all profitability ratios
for Orion Oyj.
Provide ROE
for Orion Oyj.
Provide ROA
for Orion Oyj.
Provide ROIC
for Orion Oyj.
Provide ROCE
for Orion Oyj.
Provide Gross Margin
for Orion Oyj.
Provide Operating Margin
for Orion Oyj.
Provide Net Margin
for Orion Oyj.
Provide FCF Margin
for Orion Oyj.
Show all solvency ratios
for Orion Oyj.
Provide D/E Ratio
for Orion Oyj.
Provide D/A Ratio
for Orion Oyj.
Provide Interest Coverage Ratio
for Orion Oyj.
Provide Altman Z-Score Ratio
for Orion Oyj.
Provide Quick Ratio
for Orion Oyj.
Provide Current Ratio
for Orion Oyj.
Provide Cash Ratio
for Orion Oyj.
What is the historical Revenue growth
over the last 5 years for Orion Oyj?
What is the historical Net Income growth
over the last 5 years for Orion Oyj?
What is the current Free Cash Flow
of Orion Oyj?
Discuss the annual earnings per share (EPS)
trend over the past five years for Orion Oyj.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
FI |
O
|
Orion Oyj
OMXH:ORNBV
|
7.8B EUR | 5.2 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
775.3B USD | 17.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
373.9B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK | 7.1 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
223.1B CHF | 3.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
178B GBP | 4.3 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
197.4B CHF | 4.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
219.3B USD | 3.4 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 72.3 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
140B USD | 2.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
FI |
O
|
Orion Oyj
OMXH:ORNBV
|
Average P/S:
63.8
5.2
|
10%
|
0.5 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
17.2
|
22%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
3%
|
1.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
7.1
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.8
|
5%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4.3
|
7%
|
0.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.4
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
72.3
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
0%
|
N/A |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.